The global landscape for acid-suppression therapy is undergoing a significant transformation as pharmaceutical manufacturers pivot from blockbuster reliance to diversified therapeutic portfolios. According to Proton Pump Inhibitors Market Business Insights, the current market momentum is driven by the staggering prevalence of gastroesophageal reflux disease (GERD), which now affects...
English
Kurmanji
Arabic
French
فِارسي
Deutsch
Dutch
Russian
Greek